Cargando…

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance

We have previously reported a novel phenotype of myeloid suppressors in lymphoma patients characterized by a loss of HLA-DR expression on monocytes, CD14(+)HLA-DR(low/neg). These cells were directly immunosuppressive and were associated with poor clinical outcome. In this study, we found that lympho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhe (Jenny), Bulur, Peggy A, Dogan, Ahmet, Gastineau, Dennis A, Dietz, Allan B, Lin, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485750/ https://www.ncbi.nlm.nih.gov/pubmed/26137410 http://dx.doi.org/10.1080/2162402X.2014.996470

Ejemplares similares

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)

Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses
por: Laborde, Rebecca R., et al.
Publicado: (2014)

The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019)

Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance
por: Zhang, Zhe, et al.
Publicado: (2014)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
por: Zhang, Zhe (Jenny), et al.
Publicado: (2013)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients
por: Hingorani, Pooja, et al.
Publicado: (2015)

Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
por: Xue, GuoHui, et al.
Publicado: (2021)

A method for non-overlapping identification of human myeloid derived suppressor cells
por: Gustafson, Michael, et al.
Publicado: (2014)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/−) monocytes in B-cell non-Hodgkin lymphoma
por: Xiu, B, et al.
Publicado: (2015)

Tumor Microenvironment CD14(+) Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma
por: Schenk, Erin L., et al.
Publicado: (2022)

Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation
por: Asmussen, Alexander, et al.
Publicado: (2021)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients
por: Wu, Liangliang, et al.
Publicado: (2017)

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
por: Hassan, Mirhane, et al.
Publicado: (2018)

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
por: Verschoor, Chris P., et al.
Publicado: (2013)

Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
por: Ren, Xiyang, et al.
Publicado: (2022)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Increased CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
por: Wang, Zhitao, et al.
Publicado: (2019)

Circulating CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome
por: Sun, Shipeng, et al.
Publicado: (2020)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
por: Dorhoi, Anca, et al.
Publicado: (2018)

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019)

IL-6-stimulated CD11b(+)CD14(+)HLA-DR(−) myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
por: Chen, Miao-Fen, et al.
Publicado: (2014)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma
por: Markovic, Svetomir N, et al.
Publicado: (2006)

Monocyte HLA-DR in sepsis: shall we stop following the flow?
por: Monneret, Guillaume, et al.
Publicado: (2014)

HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2023)

Carotid artery plaque uptake of (11)C-PK11195 inversely correlates with circulating monocytes and classical CD14(++)CD16(−) monocytes expressing HLA-DR
por: Ammirati, Enrico, et al.
Publicado: (2018)

Operating/regenerating the beam screen and the NEG
por: Rossi, A
Publicado: (2003)

Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation
por: Kim, Oh Yoen, et al.
Publicado: (2010)

Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
por: Wu, Huang-Pin, et al.
Publicado: (2022)

Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
por: Liu, Shiyu, et al.
Publicado: (2023)

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
por: Joshi, Ila, et al.
Publicado: (2023)

Expression of mRNA levels of HLA-DRA in relation to monocyte HLA-DR: a longitudinal sepsis study
por: Cajander, SC, et al.
Publicado: (2015)

CD115(−) monocytic myeloid-derived suppressor cells are precursors of OLFM4(high) polymorphonuclear myeloid-derived suppressor cells
por: Zou, Yunyun, et al.
Publicado: (2023)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o5ddo6vitve8sac3cnhh9ak0fa